Bevan Brown

No ORCID on file · 7 papers in corpus · active 2012-2025

Study types

  • article 5
  • letter 1
  • preprint 1

Condition tags

  • adenomyosis 6
  • dysmenorrhea 2
  • mesh:D004715 1
  • chronic_pelvic_pain 1
  • mesh:D004412 1
article 2025
·doi:10.1111/1754-9485.13834

BACKGROUND: Pelvic Congestion Syndrome (PCS) is a condition characterised by chronic pelvic pain resulting from the dilation and reflux of veins within the pelvis. While pelvic pain is the primary symptom of PCS, other associated symptoms m…

letter 2024
Journal of medical imaging and radiation oncology ·doi:10.1111/1754-9485.13739

The research data are available for review if required.

article 2024
CVIR endovascular ·doi:10.1186/s42155-024-00471-5

To report the effectiveness of uterine artery embolisation (UAE) in treating adenomyosis in women who failed prior endometrial ablation (EA).

preprint 2024
·doi:10.21203/rs.3.rs-4268436/v1
article 2021
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.13304

BACKGROUND: Failing conservative therapies, uterine artery embolisation (UAE) has been proposed as a uterine-sparing option for treatment of symptomatic adenomyosis. UAE appears effective at short-term; however long-term durability is less …

article 2018
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.12767

BACKGROUND: Uterine artery embolisation (UAE) is a possible uterine-sparing treatment option for women with unsuccessful conservative management for adenomyosis-related heavy menstrual bleeding (HMB) and dysmenorrhoea. AIM: To conduct a cli…

article 2012
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/j.1479-828x.2011.01399.x

BACKGROUND: Uterine artery embolisation (UAE) has been widely described internationally, however there is a paucity of data reported from Australia. AIM: To conduct a local audit on the efficacy and safety of UAE treating symptomatic fibroi…